Vikor Scientific

Vikor Scientific

Vikor Scientific, operating as Vanta Diagnostics, is a molecular diagnostics company based in Charleston, South Carolina. The firm has not publicly disclosed its founding year, AUM, or named principals. Its website describes a multidisciplinary team of medical, scientific, and business professionals committed to improving clinical outcomes through rapid pathogen detection. The company's core offering is rapid molecular testing for infectious diseases, delivering results from specimen arrival in under 24 hours. It targets complex patients with simultaneous pathogen detection, semi-quantification, and antibiotic resistance gene testing. Vanta Diagnostics supplements results with PharmD guidance that factors in published sensitivity patterns, medication costs, and FDA guidance. The stated goal is to reduce prophylactic antibiotic use and drive value-based care. The firm's geographic footprint appears concentrated in the United States based on its Charleston address and U.S.-focused trend reports. Vikor Scientific has not disclosed team size, additional offices, or adjacent philanthropic or operating vehicles. The firm publishes periodic Respiratory Pathogen Trend Reports; its March 2026 report covered data from December 2025 through February 2026. No recent operational events beyond these reports have been publicly documented. A structural differentiator is the integration of clinical pharmacist expertise directly into diagnostic reporting, linking laboratory results to treatment recommendations. This model positions the firm more as a clinical decision-support service than a pure laboratory testing provider.